COVID-19 Vaccine Related Topics 
Bill of Health
OCTOBER 21, 2022
COVID-19 vaccines are extremely safe , and serious harms are rare. But rare does not mean the risk is zero; thus, we need a way to determine which people have plausible claims of harm from the vaccines, and we must then compensate them quickly and generously. By Dorit Reiss. Nevertheless, rare injuries do happen.
Bill of Health
JANUARY 24, 2022
Centers for Disease Control and Prevention (CDC) is failing parents by preventing off-label use of our existing COVID-19 vaccines in the under-five set. The CDC, through its vaccine provider agreements, prevents physicians and parents from pursuing off-label use of COVID-19 vaccinations in young children.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bill of Health
NOVEMBER 8, 2022
In June 2022, after almost two years of debate over a potential COVID-19 vaccine patent waiver, the World Trade Organization adopted the Ministerial Decision on the TRIPS Agreement (“WTO Decision”), which provided for a partial waiver of intellectual property rights. By Sarah Gabriele. appeared first on Bill of Health.
Healthcare It News
FEBRUARY 1, 2022
With rising case numbers in across the DACH (Germany, Austria and Switzerland) region and the rest of Europe, a fully vaccinated status might become compulsory for the use of the EU Digital COVID Certificate (EUDCC) soon – at least in some countries. WHY IT MATTERS.
Healthcare Dive
FEBRUARY 8, 2022
The company estimated revenue from its COVID-19 vaccine and new antiviral pill Paxlovid will total $54 billion this year.
Bill of Health
JANUARY 12, 2023
government committed more than one billion dollars to Moderna for development of its COVID-19 vaccines. Moderna has since made over $30 billion in COVID-19 vaccine sales. The post COVID-19 Vaccine Patent Infringement? Indeed, as made public, the U.S.
Healthcare Dive
AUGUST 31, 2022
The commercial market for COVID-19 vaccinations could be similar to that for seasonal flu shots and other vaccines, the department said.
Expert insights. Personalized for you.
363 
Let's personalize your content